- Home
- ECCC vs CADL Comparison
ECCC vs CADL Comparison
Compare ECCC & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECCC | CADL |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ECCC | CADL |
|---|---|---|
| Price | $24.75 | $5.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.43 |
| AVG Volume (30 Days) | N/A | ★ 1.0M |
| Earning Date | N/A | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $4.25 |
| 52 Week High | N/A | $13.68 |
Technical Indicators
Market Signals| Indicator | ECCC | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 72.11 | 57.46 |
| Support Level | $24.56 | $5.45 |
| Resistance Level | $25.00 | $6.14 |
| Average True Range (ATR) | 0.25 | 0.42 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 84.60 | 45.28 |
Price Performance
Historical ComparisonAbout ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031
Eagle Point Credit Co Inc. is an externally managed, non-diversified closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective of capital appreciation. The Company seeks to achieve its investment objectives by investing in equity and junior debt tranches of collateralized loan obligations ("CLOs") collateralized by a portfolio consisting of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Company intends to operate so as to qualify to be taxed as a regulated investment company.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.